Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-12-07 Quinn Anthony G. Interim CEO Purchase +2,800 $4.99 $14K 34,809
2017-12-06 Quinn Anthony G. Interim CEO Purchase +4,888 $4.92 $24K 32,009
2017-12-05 York Charles N II Chief Financial Officer and VP Purchase +10,241 $4.76 $49K 34,787
2017-12-05 Quinn Anthony G. Director Purchase +5,065 $4.93 $25K 27,121
2017-12-04 York Charles N II Chief Financial Officer and VP Purchase +3,259 $4.97 $16K 24,546
2017-12-04 Quinn Anthony G. Director Purchase +7,956 $4.98 $40K 22,056
2017-12-01 York Charles N II Chief Financial Officer and VP Purchase +6,500 $4.59 $30K 21,287
2017-12-01 Shanafelt Armen Director Grant or award · Director Stock Option (right to buy) +30,000 30,000
2017-12-01 Quinn Anthony G. Director Purchase +4,100 $4.53 $19K 14,100
2017-12-01 Mahatme Sandesh Director Grant or award · Director Stock Option (right to buy) +30,000 30,000
2017-12-01 GEORGIOU GEORGE Director Grant or award · Director Stock Option (right to buy) +30,000 30,000
2017-12-01 Cox Russell J. Director Grant or award · Director Stock Option (right to buy) +30,000 30,000
2017-08-31 Quinn Anthony G. Interim CEO Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2017-08-22 York Charles N II Chief Financial Officer and VP Grant or award · Employee Stock Option (right to buy) +58,500 58,500
2017-08-22 Wooldridge James Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +165,000 165,000
2017-08-22 Wooldridge James Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +10,000 10,000
2017-08-22 TYLER JOSEPH E VP, Manufacturing Grant or award · Employee Stock Option (right to buy) +25,000 25,000
2017-08-22 Schuchart Aaron Chief Business Officer Grant or award · Employee Stock Option (right to buy) +10,000 10,000
2017-08-22 Rowlinson Scott W VP, Research Grant or award · Employee Stock Option (right to buy) +25,000 25,000
2017-08-15 York Charles N II Chief Financial Officer and VP Purchase +1,959 $2.52 $5K 14,787

Page 18 of 19 · 372 trades